| sympathomimetic; at low doses: increases renal blood flow | | |
| pure alpha adrenergic agonist | | |
| beta-1 selective receptor blocker | | |
| noradrenergic reuptake inhibitor | | |
| beta-2 selective agonist | | |
| indirect acting sympathomimetic | | |
| contraindicated in patients using MAO inhibitors | | |
| Effective in reversing respiratory and cardiovascular effects of anaphylactic shock | | |
| centrally-acting; reduces sympathetic outflow | | |
| CNS stimulant; appetite suppressant | | |